MD Onyinye C. Onyekwere , RN, MN Leslie Hoover , MD Renuka Gera , MD Roshni Kulkarni , MD, PhD Ajovi B. Scott-Emuakpor
{"title":"Sickle cell disease in children: Update for the primary care provider","authors":"MD Onyinye C. Onyekwere , RN, MN Leslie Hoover , MD Renuka Gera , MD Roshni Kulkarni , MD, PhD Ajovi B. Scott-Emuakpor","doi":"10.1016/S1082-7579(98)00032-6","DOIUrl":"10.1016/S1082-7579(98)00032-6","url":null,"abstract":"<div><p>Sickle cell disease is an inherited disorder characterized by sickleshaped red blood cells under conditions of low oxygenation. This leads to complications in circulation and many organ systems. The problems encountered by growing children and their families are complicated and affect every aspect of life. The multidisciplinary team is best able to work with families toward a goal of prevention and optimal growth and development.</p></div>","PeriodicalId":100909,"journal":{"name":"Medical Update for Psychiatrists","volume":"3 6","pages":"Pages 205-208"},"PeriodicalIF":0.0,"publicationDate":"1998-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1082-7579(98)00032-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89604847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Author index for volume 3","authors":"","doi":"10.1016/S1082-7579(98)00036-3","DOIUrl":"https://doi.org/10.1016/S1082-7579(98)00036-3","url":null,"abstract":"","PeriodicalId":100909,"journal":{"name":"Medical Update for Psychiatrists","volume":"3 6","pages":"Page 219"},"PeriodicalIF":0.0,"publicationDate":"1998-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1082-7579(98)00036-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137351534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Management of children with bleeding disorders","authors":"MD Renuka Gera","doi":"10.1016/S1082-7579(98)00025-9","DOIUrl":"10.1016/S1082-7579(98)00025-9","url":null,"abstract":"<div><p>Bleeding and easy bruising in children may be due to one of the many inherited or acquired disorders of hemostasis. An understanding of normal hemostasis is essential for evaluation of a child with abnormal bleeding. A complex interaction between vascular endothelium, von Willebrand factor and procoagulant protein Factor I to XIII results in formation of a fibrin clot at the site of injury and bleeding stops. Conditions causing quantitative or qualitative defects of platelets, von Willebrand factor or various procoagulant protein will result in abnormal bleeding. Patients with hemophilia experience more severe bleeding and are diagnosed early in life. von Willebrand disease on the contrary has a variable presentation and therefore the diagnosis is delayed in some cases. Morbidity and mortality due to bleeding may be reduced with appropriate management in the majority of patients with bleeding disorders. A systematic approach to a patient with bleeding is discussed. Management of hemophilia and von Willebrand disease is also reviewed.</p></div>","PeriodicalId":100909,"journal":{"name":"Medical Update for Psychiatrists","volume":"3 6","pages":"Pages 209-212"},"PeriodicalIF":0.0,"publicationDate":"1998-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1082-7579(98)00025-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90212592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Skin conditions in athletes","authors":"MD Stephen C. Ho, MD Gary McCracken","doi":"10.1016/S1082-7579(98)00034-X","DOIUrl":"10.1016/S1082-7579(98)00034-X","url":null,"abstract":"<div><p>Sports-related skin conditions have become more prevalent and better recognized as more people are participating in athletic activities. The types of dermatoses encountered may be categorized as traumatic injuries, environmental injuries, infections, and the exacerbation of preexisting skin conditions. Understanding the pathophysiology of these conditions is important since most may be avoided with proper preventative measures.</p></div>","PeriodicalId":100909,"journal":{"name":"Medical Update for Psychiatrists","volume":"3 6","pages":"Pages 202-204"},"PeriodicalIF":0.0,"publicationDate":"1998-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1082-7579(98)00034-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77326783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cardiovascular risk factors and psychiatric illness","authors":"MD William R. Yates, MD Harold Brooks","doi":"10.1016/S1082-7579(98)00023-5","DOIUrl":"10.1016/S1082-7579(98)00023-5","url":null,"abstract":"<div><p>Psychiatric illness and cardiovascular disease occur together more frequently than expected then by chance alone. Several of the established risk factors for coronary artery disease account for this increased risk of comorbidity. Psychiatric illness appears to increase the risk for hypertension. Smoking rates are higher in patients with psychiatric illness than for populations without psychiatric illness. Elevated serum cholesterol levels often occur in panic and other anxiety disorders. In contrast, there is accumulating evidence that low cholesterol levels are linked to violent death, including suicide. Myocardial infarction represents a major life stressor that can precipitate an episode of major depression. Prolonged depression following myocardial infarction can become an independent risk factor for cardiac mortality. These associations increase the need for psychiatrists to be aware of the risk factors for coronary heart disease and to assist with the assessment and management of these risk factors in patients with mental illness.</p></div>","PeriodicalId":100909,"journal":{"name":"Medical Update for Psychiatrists","volume":"3 6","pages":"Pages 196-201"},"PeriodicalIF":0.0,"publicationDate":"1998-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1082-7579(98)00023-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73057960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Drug-induced sexual dysfunction","authors":"PharmD Suzanne E. Fecik","doi":"10.1016/S1082-7579(98)00024-7","DOIUrl":"10.1016/S1082-7579(98)00024-7","url":null,"abstract":"<div><p>Drug-induced sexual dysfunction is a common barrier to the treatment of mental illnesses. To further confound the matter, disease states such as depression, schizophrenia, diabetes, and hypertension all can decrease sexual desire and increase difficulty with erectile function and problems with orgasm. An assessment of baseline sexual functioning is often overlooked, making it difficult to determine whether the illness or the medication is responsible for the problems. Patients should be informed about the possibility of this side effect and encouraged to report any changes in functioning to their physician. Three main stages of sexual function are affected by medications, including: desire-libido; arousal-priapism and impotence (erectile dysfunction); and orgasmanorgasmia, delayed ejaculation, and painful orgasm. Treatment strategies include decreasing the dose of the current pharmacologic therapy, switching to another class of medication, or adding another agent. Treatment of sexual dysfunction will help to improve medication compliance, thereby reducing the risk of a relapse.</p></div>","PeriodicalId":100909,"journal":{"name":"Medical Update for Psychiatrists","volume":"3 6","pages":"Pages 176-181"},"PeriodicalIF":0.0,"publicationDate":"1998-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1082-7579(98)00024-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79380552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Review and update on oral contraceptives for the psychiatric practitioner","authors":"PharmD Andrea L. Coffee, MD Patricia J. Sulak","doi":"10.1016/S1082-7579(98)00029-6","DOIUrl":"10.1016/S1082-7579(98)00029-6","url":null,"abstract":"<div><p>Oral contraceptive therapy is used by many women of contraceptive age. Although an effective contraceptive, other uses include menstrual problems such as menorrhagia and dysmenorrhea and premenstrual syndrome. Because of the prevalence of use, psychiatric practitioners should be familiar with their components and educational tools that improve product selection and patient compliance. Oral contraceptives containing ethinyl estradiol 35 mcg or less are used by most women today. Much of the documentation of adverse effects are from the higher dose products used in the past. Many women are not aware of the many noncontraceptive benefits such as decreased incidences of breast and ovarian cancer and improvements in menstrual problems. Oral contraceptives are associated with increased thromboembolic disease, but the risk is less than the risk in pregnancy. Other health risks have not been conclusively proven or the increased risk is so small that the benefits often outweigh the risks. Drug interactions with commonly encountered concomitant drugs are also discussed.</p></div>","PeriodicalId":100909,"journal":{"name":"Medical Update for Psychiatrists","volume":"3 6","pages":"Pages 213-218"},"PeriodicalIF":0.0,"publicationDate":"1998-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1082-7579(98)00029-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90457252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Subject index for volume 3","authors":"","doi":"10.1016/S1082-7579(98)00037-5","DOIUrl":"https://doi.org/10.1016/S1082-7579(98)00037-5","url":null,"abstract":"","PeriodicalId":100909,"journal":{"name":"Medical Update for Psychiatrists","volume":"3 6","pages":"Pages 220-222"},"PeriodicalIF":0.0,"publicationDate":"1998-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1082-7579(98)00037-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137351533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
MBA, PharmD, FAC Robert L. Barkin (Associate Professor of Anesthesiology) , BS Diana S. Barkin , BS, MED, SCAC, PsyD Candidate Stacy J. Barkin , BS Stephanie A. Barkin
{"title":"Opiate, opioids, and centrally acting analgesics and drug interactions: The emerging role of the psychiatrist","authors":"MBA, PharmD, FAC Robert L. Barkin (Associate Professor of Anesthesiology) , BS Diana S. Barkin , BS, MED, SCAC, PsyD Candidate Stacy J. Barkin , BS Stephanie A. Barkin","doi":"10.1016/S1082-7579(98)00033-8","DOIUrl":"10.1016/S1082-7579(98)00033-8","url":null,"abstract":"<div><p>The psychiatrist and other mental health providers are frequently consulted for the most appropriate choice of analgesics for patients under their care. The choice is multifactional in selecting an appropriate opiate/opioid analgesic. Among opportunities in the selection process, the psychiatrist must consider pharmacologic, pharmacokinetic, and pharmacotherapeutic effects when prescribing opiates/opioids to patients under their care. Implicit in the decision process is the cytochrome PC450 system induction or inhibition changes by psychopharmacologic agents. Additionally, one must consider therapeutic and non-therapeutic metabolites that opiates provide to the patient that overlay the patient's concurrent psychopathology. This article focuses on the selection process and the cytochrome PC450 used by opiates/opioids.</p></div>","PeriodicalId":100909,"journal":{"name":"Medical Update for Psychiatrists","volume":"3 6","pages":"Pages 171-175"},"PeriodicalIF":0.0,"publicationDate":"1998-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1082-7579(98)00033-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89774811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Psychiatric issues and human immunodeficiency virus-associated dementia","authors":"MD Ned Sacktor","doi":"10.1016/S1082-7579(98)00027-2","DOIUrl":"10.1016/S1082-7579(98)00027-2","url":null,"abstract":"<div><p>Neurological and psychiatric morbidity are commonly associated with advanced HIV infection. Dementia, delirium, major depression, and mania usually are confined to the symptomatic stages of HIV infection. Cognition, behavior, and motor function abnormalities all are associated with HIV dementia. HIV dementia and major depression may occur together or as separate conditions in AIDS patients. Neuropsychological testing is useful in distinguishing dementia from depression. The diagnostic work-up for HIV dementia includes a detailed history and physical examination, neuropsychological testing, laboratory studies including cerebrospinal fluid analysis, and neuroimaging. Effective treatment is available for some patients with HIV dementia, depression, and mania.</p></div>","PeriodicalId":100909,"journal":{"name":"Medical Update for Psychiatrists","volume":"3 6","pages":"Pages 182-186"},"PeriodicalIF":0.0,"publicationDate":"1998-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1082-7579(98)00027-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80152263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
